Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression.

Source:http://linkedlifedata.com/resource/pubmed/id/18096165

Download in:

View as

General Info

PMID
18096165